Albany Molecular Research, Inc.
Drug discovery firm reports 22.2% decrease in revenues
Published in Lab Business Week, September 19th, 2004
Total revenue for the second quarter of 2004 was $42.0 million, a 22.2% decrease compared to $54.0 million in the second quarter of 2003. Total contract revenue for the second quarter of 2004 was $28.1 million, a 27.6% decrease compared to total contract revenue of $38.8 million during the second quarter of 2003.
Recurring royalties for the second quarter of 2004 were $13.9 million, a decrease of $1.3 million, or 8.6%, from recurring royalties of $15.2 million in the second quarter of 2003. AMRI earns royalties from worldwide sales of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-09-19)
More Articles from Lab Business Week
- Access Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.17 per share - Akorn, Inc.
Pharmaceutical firm reports 25% increase in revenues - Alkermes, Inc.
Pharmaceutical firm reports loss of $0.40 per share - America Oriental Bioengineering
Chinese biotech firm reports 23% revenue increase - Anadys Pharmaceuticals, Inc.
Hepatitis drug maker reports loss of $0.50 per share - Antares Pharma, Inc.
Pharmaceutical firm reports 24% decrease in revenue - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
